NPTX2 and early-onset autosomal dominant Alzheimer disease: For neurodegenerative conditions, such as Parkinson's disease, Alzheimer's disease, ALS, and FTD, NP2's involvement in synaptic homeostasis and degeneration positions it as a valuable biomarker for early diagnosis and disease monitoring.